Highest-materiality recent filing
Q4 2025 revenue $1.8B (+20% YoY), record full-year revenue $7.1B (+35%).
CME Group Announces Pricing Changes via Special Executive Report 9676
On February 2, 2026, CME Group communicated pricing changes to clients in Special Executive Report 9676.
CME Group Inc. reports financial results for quarter ended June 30, 2025
CME Group issued a press release on July 23, 2025 reporting its financial results for the quarter ended June 30, 2025.
CME Group and S&P Global sell OSTTRA joint venture to KKR for $3.1B
Total enterprise value of $3.1 billion; proceeds split 50/50 between CME and S&P Global.
CME Group declares $2.1B annual variable dividend ($5.80/share) and $3B share repurchase program
Annual variable dividend of $5.80 per share ($2.1B total) payable Jan 16, 2025 to holders of record Dec 27, 2024.
the Company announced that Ms. Julie Holzrichter has decided to step down from her role as Chief Operating Officer, a position she held since 2014.
Ms. Suzanne Sprague who has served as our Senior Managing Director & Global Head of Clearing and Post-Trade Services since February 2022 has also assumed the role of Chief Operating Officer.
Ms. Lynne Fitzpatrick has been promoted to President and Chief Financial Officer.
on July 8, 2024, Mr. Dennis notified the Company of his intent to retire from the Company’s Board of Directors, effective immediately.
Michael G. Dennis will be joining CME Group Inc. (the “CME Group” or the “Company”) as of August 5, 2024 in the role of Senior Managing Director Global Head, Fixed Income.
Max materiality 0.85 · Median 0.50 · Most common event earnings